Fig. 5: Computational approaches for advancing microbiome- and ACE2-targeted therapies in diabetic retinopathy. | npj Systems Biology and Applications

Fig. 5: Computational approaches for advancing microbiome- and ACE2-targeted therapies in diabetic retinopathy.

From: Systems biology and microbiome innovations for personalized diabetic retinopathy management

Fig. 5

Synthetic biology approaches, such as engineered probiotics, together with computational frameworks, enable the design and validation of next-generation therapeutic interventions (DR diabetic retinopathy, AI artificial intelligence, ML machine learning, DL deep learning, MD molecular dynamics, PLM protein language model).

Back to article page